News NICE backs Keytruda for incurable cervical cancer via CDF Hundreds of NHS patients with an incurable form of cervical cancer will be able to get treatment using a combination regimen based on Merck & Co/MSD’s cancer immunothe
News PTC’s gene therapy for rare disease cleared for NHS use Upstaza has shown impressive clinical results in children with fatal disorder AADC deficiency.
News An aura of adult migraine hope as NICE recommends Vyepti Lundbeck’s eptinezumab receives NICE recommendation for the prevention of migraine in adults.
News More digital mental health therapies backed for NHS use Online CBT programmes could help 40,000 people with depression and anxiety-related conditions.
News NICE okays neoadjuvant Opdivo in lung cancer BMS' checkpoint inhibitor is first to be given a green light for use before surgery in NSCLC.
News As pandemic abates, NICE issues new COVID drug guidance NICE says it is the first HTA to give guidance on the drugs outside of use during the pandemic.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.